Literature DB >> 27278899

Heterogeneous oxacillin-resistant phenotypes and production of PBP2A by oxacillin-susceptible/mecA-positive MRSA strains from Africa.

Marilyn Chung1, Choon Keun Kim1, Teresa Conceição2, Marta Aires-De-Sousa3, Hermínia De Lencastre4, Alexander Tomasz5.   

Abstract

OBJECTIVES: Recent surveillance of MRSA colonizing patients and healthcare workers in two African countries (Angola and São Tomé and Príncipe) reported the frequent recovery of oxacillin-susceptible MRSA (OS-MRSA): Staphylococcus aureus strains that gave positive results with the mecA DNA probe, but had low oxacillin MIC values characteristic of susceptible S. aureus. This apparent dissociation of the drug-resistant phenotype from mecA-the primary genetic determinant of resistance-prompted us to perform a more detailed analysis on nine of the African OS-MRSA strains.
METHODS: Oxacillin MIC values were determined by Etest and population analysis profiles with and without induction of the stringent stress response by mupirocin. Biochemical profiling using SDS-PAGE followed by western blotting was used for the detection of PBP2A protein produced.
RESULTS: Cultures of the African MRSA strains (ST88-IVa and ST8-V) showed heterogeneous oxacillin resistance in which the majority of cells exhibited low oxacillin MICs (≤0.75 mg/L), but highly resistant subpopulations were also present with oxacillin MIC values up to several hundred mg/L and with frequencies of 10(-4) to 10(-6). The same strains after induction of the stringent stress response by mupirocin 'converted' the heterogeneous phenotypes into a more homogeneous and higher level resistance. After induction by oxacillin and mupirocin, each of the nine African OS-MRSA strains produced PBP2A-the protein product of mecA.
CONCLUSIONS: The resistant phenotype of OS-MRSA resembles the phenotypes of historically early MRSA clones. The nature of genetic determinants responsible for the heterogeneous phenotypes of OS-MRSA remains to be determined.
© The Author 2016. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27278899      PMCID: PMC5031915          DOI: 10.1093/jac/dkw209

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  24 in total

1.  Frequent occurrence of oxacillin-susceptible mecA-positive Staphylococcus aureus (OS-MRSA) strains in two African countries.

Authors:  Teresa Conceição; Céline Coelho; Hermínia de Lencastre; Marta Aires-de-Sousa
Journal:  J Antimicrob Chemother       Date:  2015-08-27       Impact factor: 5.790

2.  Update to the multiplex PCR strategy for assignment of mec element types in Staphylococcus aureus.

Authors:  Catarina Milheiriço; Duarte C Oliveira; Hermínia de Lencastre
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191

3.  Multiplex PCR strategy for subtyping the staphylococcal cassette chromosome mec type IV in methicillin-resistant Staphylococcus aureus: 'SCCmec IV multiplex'.

Authors:  Catarina Milheiriço; Duarte C Oliveira; Hermínia de Lencastre
Journal:  J Antimicrob Chemother       Date:  2007-04-28       Impact factor: 5.790

4.  Prevalence and molecular typing of oxacillin-susceptible mecA-positive Staphylococcus aureus from multiple hospitals in China.

Authors:  Wenqiang He; Hongbin Chen; Chunjiang Zhao; Feifei Zhang; Hui Wang
Journal:  Diagn Microbiol Infect Dis       Date:  2013-08-28       Impact factor: 2.803

5.  Methicillin-resistant Staphylococcus aureus: comparison of susceptibility testing methods and analysis of mecA-positive susceptible strains.

Authors:  G Sakoulas; H S Gold; L Venkataraman; P C DeGirolami; G M Eliopoulos; Q Qian
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

6.  The evolution of methicillin resistance in Staphylococcus aureus: similarity of genetic backgrounds in historically early methicillin-susceptible and -resistant isolates and contemporary epidemic clones.

Authors:  M I Crisóstomo; H Westh; A Tomasz; M Chung; D C Oliveira; H de Lencastre
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

7.  In vitro and in vivo evaluations of oxacillin efficiency against mecA-positive oxacillin-susceptible Staphylococcus aureus.

Authors:  Alexandros Ikonomidis; George Michail; Afroditi Vasdeki; Maria Labrou; Vasilis Karavasilis; Constantinos Stathopoulos; Antonios N Maniatis; Spyros Pournaras
Journal:  Antimicrob Agents Chemother       Date:  2008-08-11       Impact factor: 5.191

8.  Characterization of oxacillin-susceptible mecA-positive Staphylococcus aureus: a new type of MRSA.

Authors:  Yasuko Hososaka; Hideaki Hanaki; Harumi Endo; Yumiko Suzuki; Zenzo Nagasawa; Yoshihito Otsuka; Taiji Nakae; Keisuke Sunakawa
Journal:  J Infect Chemother       Date:  2007-05-08       Impact factor: 2.211

9.  Inducibility and potential role of MecA-gene-positive oxacillin-susceptible Staphylococcus aureus from colonized healthcare workers as a source for nosocomial infections.

Authors:  G Kampf; S Adena; H Rüden; K Weist
Journal:  J Hosp Infect       Date:  2003-06       Impact factor: 3.926

10.  Oxacillin-susceptible methicillin-resistant Staphylococcus aureus (OS-MRSA), a hidden resistant mechanism among clinically significant isolates in the Wessex region/UK.

Authors:  K Saeed; N Ahmad; M Dryden; N Cortes; P Marsh; A Sitjar; S Wyllie; S Bourne; J Hemming; C Jeppesen; S Green
Journal:  Infection       Date:  2014-06-12       Impact factor: 3.553

View more
  8 in total

Review 1.  Mechanisms and clinical relevance of bacterial heteroresistance.

Authors:  Dan I Andersson; Hervé Nicoloff; Karin Hjort
Journal:  Nat Rev Microbiol       Date:  2019-06-24       Impact factor: 60.633

2.  Emergence of Oxacillin Resistance in Stealth Methicillin-Resistant Staphylococcus aureus Due to mecA Sequence Instability.

Authors:  Richard V Goering; Erin A Swartzendruber; Anne E Obradovich; Isabella A Tickler; Fred C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

3.  Using genomics to understand meticillin- and vancomycin-resistant Staphylococcus aureus infections.

Authors:  Stefano G Giulieri; Steven Y C Tong; Deborah A Williamson
Journal:  Microb Genom       Date:  2020-01

4.  Identification and characterization of mutations responsible for the β-lactam resistance in oxacillin-susceptible mecA-positive Staphylococcus aureus.

Authors:  Tanit Boonsiri; Shinya Watanabe; Xin-Ee Tan; Kanate Thitiananpakorn; Ryu Narimatsu; Kosuke Sasaki; Remi Takenouchi; Yusuke Sato'o; Yoshifumi Aiba; Kotaro Kiga; Teppei Sasahara; Yusuke Taki; Feng-Yu Li; Yuancheng Zhang; Aa Haeruman Azam; Tomofumi Kawaguchi; Longzhu Cui
Journal:  Sci Rep       Date:  2020-10-09       Impact factor: 4.379

5.  Clonal Diversity, Low-Level and Heterogeneous Oxacillin Resistance of Oxacillin Sensitive MRSA.

Authors:  Roushan Liu; Jian Zhang; Xiaoli Du; Yingying Lv; Xiangyu Gao; Yanyan Wang; Junrui Wang
Journal:  Infect Drug Resist       Date:  2021-02-19       Impact factor: 4.003

6.  Genomic Basis of Occurrence of Cryptic Resistance among Oxacillin- and Cefoxitin-Susceptible mecA-Positive Staphylococcus aureus.

Authors:  Bingshao Liang; Zhile Xiong; Zhuwei Liang; Chao Zhang; Hao Cai; Yan Long; Fei Gao; Jielin Wang; Qiulian Deng; Huamin Zhong; Yongqiang Xie; Lianfen Huang; Sitang Gong; Zhenwen Zhou
Journal:  Microbiol Spectr       Date:  2022-05-24

7.  Molecular Evolution and Genomic Insights into Community-Acquired Methicillin-Resistant Staphylococcus aureus Sequence Type 88.

Authors:  Wei Wang; Hui Li; Menghan Li; Yinping Dong; Yao Bai; Fengqin Li; Jing Xiao
Journal:  Microbiol Spectr       Date:  2022-06-22

8.  Detection of diverse genotypes of Methicillin-resistant Staphylococcus aureus from hospital personnel and the environment in Armenia.

Authors:  Hermine V Mkrtchyan; Zhen Xu; Maria Yacoub; Mary M Ter-Stepanyan; Hayk D Karapetyan; Angela M Kearns; Ronald R Cutler; Bruno Pichon; Armen Dz Hambardzumyan
Journal:  Antimicrob Resist Infect Control       Date:  2017-02-07       Impact factor: 4.887

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.